Finished
Randomized Trial of Wound Infiltration With Extended-release Bupivacaine Before Laparoscopic or Robotic Hysterectomy
NCT02352922 · AdventHealth · Updated 1 Oct 2020
- What is being tested
- Liposomal Bupivacaine; Bupivacaine HCl
- For
- Pain, Postoperative; Surgical Procedure, Unspecified
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years and older. About 64 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started July 2015, ends Feb 2016. Registered 2 Feb 2015.
- Results
- Posted on the registry on 1 Oct 2020.
In the researchers' words
The investigators are studying ways to improve pain control after surgery. One way to decrease pain is to inject incisions with a numbing medicine (local anesthetic) while in the operating room. There is an FDA approved extended-release version of a commonly used local anesthetic (bupivacaine) that can last for 4 days instead of 6 hours. The investigators are studying whether using the extended-release medication (Exparel) will give better pain relief after laparoscopic and robotic-assisted hysterectomies.
Sites
- Florida Hospital OrlandoOrlando, Florida, United States